- Added to Email Alerts
AMD and Retinal Disease
Latest News View All
-
FDA Declines to OK Outlook Therapeutics' Eye Disease Drug
-
Even an Hour's Walk a Week Lowers Risk in Type 2 Diabetes
-
US FDA Approves Higher Dose Regeneron Eye Disease Drug Eylea
-
ASRS 2023Long-Term Outcomes of Pegcetacoplan for GA Show Promise
-
ASRS 2023Complications From Geographic Atrophy Drug Fuel Questions
-
Regeneron Expects FDA Decision on Higher-Dose Eylea in 2023
-
ASRS 2023Do GLP-1 Agonists Worsen Diabetic Retinopathy?
-
Biosimilars Comparable to Aflibercept in Macular Disease
Perspective View All
Journal Articles View All
-
Bloodstream Infections After Congenital Heart Surgery
-
Outcomes After Adolescent Metabolic and Bariatric Surgery
-
Safety of Recent Ophthalmic Drugs and Devices for Wet AMD
-
Refractive Surgery for the Glaucoma Suspect
-
Visual Hallucinations: Psychiatric vs. Neurologic Causes
-
Urinary Nitrate and Diabetes Complications and Mortality
Additional Resources
Medscape Drugs & Diseases
- Exudative ARMD
- Lattice Degeneration
- Nonexudative ARMD
- Retinal Detachment, Exudative
- Valsalva Retinopathy
Medscape Education